Dr. Yael Schenker Receives AHRQ RO1

(July 26th, 2023) Dr. Yael Schenker and Dr. Lindsay Sabik have been awarded R01 funding from the Agency for Healthcare Research and Quality (AHRQ) for a forthcoming study entitled, “Policies to Inform Safe and Equitable Opioid Access for Patients with Advanced Cancer Near End of Life (PICASSO)” The project will clarify what impact state-level policies have on advanced cancer patients. Read more at NIH Reporter.

Congratulations, Dr. Schenker and Dr. Sabik!